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Abstract
Objective—To compare a central analgesic mechanism known as diffuse noxious inhibitory 
controls (DNIC) using somatic test stimuli and somatic conditioning stimuli, (CS) in irritable 
bowel syndrome (IBS) patients and healthy controls.
Methods—Participants were 48 premenopausal females (27 with IBS), mean age of 29 years. 
The phasic heat test stimulus (peak temperature, 50°C) was applied to the left palm. The DNIC 
effect, which measured reductions in average pain ratings (APR) during counter irritation 
(submersion of the participant’s right hand in painful 12°C circulating water) compared with 
baseline, was compared between groups. In addition, a second, counterbalanced, CS protocol 
(right hand submerged in nonpainful 32°C circulating water) was performed. Differences in APR 
between the 2 counter-irritation protocols were compared between groups to control for 
nonspecific effects known to influence DNIC. Psychologic measures and cardiovascular reactivity 
were also assessed.
Results—IBS patients demonstrated smaller DNIC than controls (P=0.011, repeated measures 
analysis of variance), and greater state-anxiety, depression, catastrophizing, and anger-out 
expression (P<0.05). Group differences in DNIC were enhanced after controlling for nonspecific 
effects occurring during the nonpainful CS, and for psychologic measures (P=0.001, repeated 
measures analysis of covariance). There were no group differences in age, cardiovascular 
reactivity, APR, or pain ratings for the 12°C CS.
Discussion—These data demonstrate deficient DNIC in IBS. This is the first study to 
adequately control for alternative explanations of pain reduction during counterirritation. Only by 
controlling for nonspecific effects can evidence of deficient DNIC be attributed to dysregulation in 
endogenous analgesic mechanisms.
Copyright © 2010 by Lippincott Williams & Wilkins
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Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by 
recurring abdominal pain associated with altered bowel habits in patients who do not show 
signs or symptoms of an alternative disease to explain these symptoms.1 Many IBS patients 
have been found to be hypersensitive to balloon distension of the colon and rectum.2–4 
Although not all IBS patients demonstrate this hypersensitivity, visceral hyperalgesia is so 
common in IBS patients that it is often considered to be a biologic marker for IBS.4,5 
Contrary to earlier reports, which found evidence of visceral but not somatic hyperalgesia, 
most recent investigations have also demonstrated somatic hyperalgesia in IBS patients.6–9 
These new data suggest the possibility that IBS patients may have a dysregulation in central 
pain processing similar to that seen in other chronic pain disorders such as fibromyalgia 
syndrome (FMS) and temporomandibular disorders (TMD).10
Investigations to explore central pain dysregulation in these and other chronic pain disorders 
have focused on two aspects, namely (1) exaggerations in temporal summation that 
facilitates ascending pain signals, and (2) deficits in diffuse noxious inhibitory controls 
(DNIC) that provide tonic descending anti-nociceptive signals. Research consistently shows 
enhanced temporal summation of afferent pain signals as well as deficits in DNIC in 
FMS11–13 and TMD patients14–17 compared to healthy controls (HCs), supporting the view 
that central alteration in pain signaling is an important contributor to the onset or worsening 
of chronic pain symptoms.10,18–21 According to Lautenbacher and Rollman, the nature of 
FMS, or any chronic pain condition, points to a deficient DNIC process reflecting 
decrements in endogenous analgesic systems.11
The counterirritation phenomenon known as DNIC occurs when pain perception from one 
nociceptive stimulus is substantially inhibited by a second nociceptive stimulus administered 
somewhere else in the body.22 This inhibition is potent, affecting all of the activities of the 
wide dynamic range neurons in the dorsal horn. DNIC mechanisms act like a barrier to 
prevent the spread of pain and keep it bearable by providing a tonic inhibitory influence.21 
Deficits in DNIC are believed to play an important role in geriatric and chronic 
pain.10,18–21,23
Testing DNIC requires administering a phasic, noxious test stimulus (TS), before and 
concurrent with a tonic noxious conditioning stimulus (CS), typically, ischemic, cold 
pressure, or noxious heat pain, heteroptopically.11,13,23–25 The difference between the pain 
that is experienced with the first phasic pain stimulus, without the CS, compared with the 
second phasic stimulus of identical intensity and duration during the concurrent tonic pain is 
described as the DNIC effect.
Wilder-Smith and colleagues in 200426 reported deficits in DNIC in IBS patients compared 
with controls using a visceral TS of painful intrarectal distensions during application of a 
somatic CS (placing the foot in ice-water).26 Although these investigators report group 
differences in the activity of magnetic resonance imaging in pain regulatory centers of the 
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brain during the DNIC procedure, the choice of rectal distensions as the TS and noxious 
cold applied to the foot as the CS present several questions that need to be addressed. (1) It 
cannot be determined if the reduction in median pain scores for the TS during concurrent 
noxious CS was due to distraction from the CS, which is known to effect DNIC 
measures11,13,18 or (2) whether the lack of DNIC in IBS patients was due to hypervigilance 
to the TS of rectal distensions.27 Using painful gut distensions for IBS patients as the TS 
may complicate the evaluation of DNIC. (3) Peripheral sensitization of gut afferent fibers 
due to a history of chronic abdominal pain may interfere with the assessment of the central 
pain regulatory process of DNIC on rectal pain perception. Peripheral sensitization occurs 
when polymodal C-fiber nociceptors and A-fiber mechanonociceptors increase their 
sensitivity after repeated noxious stimulation, which is unique to the nociceptive system. 
According to Bouin and colleagues,28 dysregulation in the neurobiology of visceral (gut) 
afferents and pain sensitivity control is believed to explain IBS symptoms. (4) Convergence 
of nociceptive afferent signals from rectal distension and from cold pain at the foot that 
share transmission pathways in lumbar dorsal horn neurons may further complicate the 
assessment of the effect of the CS on the TS. Also, Wilder-Smith et al did not control for 
psychologic factors29–34 or cardiovascular reactivity,35,36 which have been shown to 
influence pain measurements. The aim of the present investigation was to assess group 
differences in central analgesic mechanisms by comparing DNIC in IBS patients and HCs 
using a somatic TS and a somatic CS, while controlling for nonspecific effects on pain 




Premenopausal women, 18 years of age and older were recruited for this investigation. IBS 
patients met Rome II criteria37 and currently had painful symptoms of IBS. Exclusion 
criteria were status postmenopause, pregnant or nursing, major clinical depression or anxiety 
disorder, hypertension, heart disease, kidney disease, diabetes mellitus, seizure disorder, 
asthma, or thyroid disorder. Individuals taking analgesics, narcotics, or antidepressants were 
also excluded from participation. Healthy participants could not have a history of any 
chronic pain conditions. All IBS subtypes were recruited, as well as IBS patients reporting 
additional chronic pain conditions. Recruitment was by campus-wide e-mail, fliers, and 
from a registry of individuals interested in participation in research from the University of 
North Carolina Center for Functional Gastrointestinal and Motility Disorders. This 
investigation was approved by the University of North Carolina Medical Institutional 
Review Board.
Design
Somatic, rather than visceral pain stimuli were used for both the test and conditioning 
stimuli to avoid interference from peripheral sensitization in the gut that may be present in 
IBS patients. In addition, pain testing was performed on the upper extremities to avoid 
convergence of nociceptive signals at lumbar dorsal horn neurons, which may occur when 
measuring simultaneous pain signaling from the lower extremities and the gastrointestinal 
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tract. Pain testing was performed during the follicular phase of the menstrual cycle (days 4 
to 8) to minimize gonadal hormone influences on pain perception. To minimize sympatho-
mimetic influences on pain perception, all participants were instructed to refrain from 
consuming caffeine and nicotine for at least 2 hours before testing and all participants were 
tested at approximately the same time in the afternoon to control for diurnal fluctuations in 
cortisol. A battery of questionnaires to identify group differences in mood, perceived stress, 
and stress coping strategies were administered. Blood pressure (BP) and heart rate (HR) 
measures were also taken at baseline and following each pain stimulus procedure.
Measures of psychologic status included the Spielberger State-Trait Anxiety Inventory,38 
the Beck Anger Expression Inventory,39 and the Beck Depression Inventory. 40 The 
Perceived Stress Scale41 measured recent exposure and responses to stress, and pain coping 
style was assessed by the Catastrophizing subscale of the Coping Strategies Questionnaire 
(CSQ).42 Characterization of current clinical pain was obtained with the Irritable Bowel 
Syndrome Severity Scale43 and the Physical Symptoms Questionnaire,44 which measures 
the frequency and intensity of comorbid pain conditions.
After the completion of the informed consent and of the questionnaires, participants were 
given a brief exposure to the phasic heat stimuli TS apparatus using the TSA-II, 
NeuroSensory Analyzer (Medoc Medical Instruments Inc, Durham, NC) and the ice-water 
CS to minimize apprehension regarding these stimuli. This consisted of a practice trial for 
the phasic heat pain stimuli and a brief exposure to the CS by submerging their right hand in 
12°C circulating water for 10 seconds.
After the brief exposures to the pain stimuli, the right arms of the participants were 
instrumented with HR and BP monitors (Acutracker, Suntech Instruments, Chapel Hill, NC). 
After a 10-minute rest, BP and HR were acquired as baseline measures. Immediately after 
each pain testing procedure, HR and BP were recorded.
Pain Testing Procedures
Baseline Thermode Pain Ratings—Phasic heat pain ratings were acquired from 2 
locations on the proximal palmar surface of the left hand. Participants were randomly 
assigned to be tested at either the heel pad or thumb pad of the left hand. Pain ratings from 
all protocols were acquired from the same location for each participant from a series of 8 
phasic thermal stimuli delivered using a 30 by 30mm contact thermode with peak 
temperatures of 50°C, baseline temperatures of 40°C, and an interstimulus interval of 3 
seconds (peak to peak). Participants were instructed to rate the intensity of the pain from 
each phasic heat stimulus on a 0 to 100 scale as soon as they noticed the peak temperature 
with 0 representing no pain, and 100 representing the most intense pain imaginable. Average 
pain ratings (APR) were acquired from the series of 8 thermal stimuli and were compared 
between the groups. Participants were informed that the procedure would be terminated if 
they gave a rating of 100 or verbally requested that the stimuli be discontinued.
DNIC—DNIC effects were assessed in 2 protocols. Both provided precisely the same phasic 
heat stimuli for the TS as was used in the baseline protocol. For 1 DNIC test, the 
participant’s right hand was submerged to the wrist in circulating water at a noxious 
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temperature (12°C), and for the second protocol, the procedure was duplicated except that 
the temperature of the water was 32°C. To control for order effects, the DNIC procedures 
using the 2 water temperatures were counter-balanced. Participants were instructed to focus 
their attention on the phasic heat pain TS throughout the DNIC procedure and not on the CS, 
to minimize the effects of distraction from the CS.
Noxious CS—Phasic heat pulses were administered in the same manner as in the baseline 
procedure. This commenced after the tonic CS (other hand submerged in 12°C water) had 
been applied for 20 seconds. The duration of phasic heat testing was 24 seconds (8 phasic 
stimuli), as in the baseline session. The CS exposure time was 44 seconds. Changes in APR 
from the phasic heat pain during baseline, to APR during counterirritation were assessed to 
compare DNIC between the groups.
Non-noxious CS—The DNIC procedure during non-noxious CS was identical to the 
procedure using noxious CS, except that the temperature of the water used for the CS was a 
neutral, non-noxious temperature (32°C). This non-noxious CS controls for nonspecific 
effects on pain perception and DNIC, such as distraction, by providing the same experience 
as was provided in the noxious counterirritation procedure except for the absence of 
nociception. For this investigation, the term “nonspecific effects” represents the effects on 
DNIC scores that are due to factors other than endogenous analgesia that DNIC protocols 
are designed to measure. Reductions in pain ratings during a non-noxious water bath CS 
cannot be due to the neurochemical process of DNIC, which requires counterirritation (pain) 
from the CS. The sequence of the noxious and non-noxious CS procedures was 
counterbalanced. Both the initial DNIC effect on APR and the DNIC effect based on the 
difference in APR during the noxious and the non-noxious conditions were compared 
between the groups.
Water Pain Ratings—Participants were also asked to rate the pain in their right hand 
caused by submersion in water for 44 seconds on the same 0 to 100 pain rating scale for 
both CS. This score was acquired immediately at the conclusion of the phasic heat pulses, to 
avoid distracting the participant from the TS, and before removing the hand from the water.
Data Analysis—Groups were compared by analysis of variance (ANOVA) with respect to 
all demographic, psychologic, and cardiovascular reactivity variables (systolic BP and HR). 
To compare sensitivity to somatic pain stimuli, 2 ANOVAs were performed with group as 
the between participants factor and (1) APR; and (2) water pain rating (WPR) as within 
factors, respectively. To compare the DNIC effect between groups, 2 repeated measures 
ANOVAs were performed with Group as the between factor and DNIC as a repeated factor: 
(1) assessing APR during baseline and during the concurrent noxious 12°C CS 
counterirritation sessions; and (2) assessing APR during baseline and during the concurrent 
non-noxious 32°C CS sessions. A repeated measures analysis of covariance was performed 
with Group as the between participants factor and DNIC as a repeated factor assessing APR 
during the noxious 12°C CS counterirritation sessions and during the concurrent non-
noxious 32°C CS session. This was done to statistically control for nonspecific effects that 
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occur during counterirritation protocols. Alpha was set at P<0.05 for all analyses (SPSS, 
15.0).
RESULTS
Forty-eight female participants were recruited for this investigation. This included 21 HC 
and 27 patients with IBS. Five IBS patients also had another chronic pain condition (3 with 
migraine headaches, 2 with TMD). Within the IBS group, 10 were diarrhea predominant 
(IBS-D), 8 were constipation predominant (IBS-C), and 9 were identified as IBS-alternators 
(IBS-A, where symptoms alternate between constipation and diarrhea). There were no 
significant differences between the IBS and HC groups on any demographic variables. 
Eighty-five percent of the IBS patients and 81% of the HC participants were college 
graduates. The mean age for the IBS group was 28.9 years and it was 28.5 years for the HC 
group. The mean body mass index was also virtually the same across groups (HC=23.9 and 
IBS=24.1). IBS patients included 25 white, 1 African American, and 1 Asian participants. 
HCs included 14 white, 3 African American, 1 Asian, 2 Native American, and 1 African 
participants.
Psychologic Outcome Measures
All psychologic questionnaires were completed before any pain perception testing. IBS 
patients reported significantly greater psychologic distress than did HC (Table 1) as 
reflected in scores on the anger-out subscale on the Anger Expression Inventory (P=0.039, 
ANOVA), the catastrophizing pain coping style subscale of the CSQ (P=0.005, ANOVA), 
the state-anxiety index of the Spielberger State-Trait Anxiety Index (P=0.008, ANOVA), 
and the Beck Depression Inventory (P=0.019, ANOVA). There were no differences on any 
psychologic measures in IBS subgroups.
Cardiovascular Reactivity Outcome Measures
There were no group differences on measures of systolic BP or HR at baseline, or after any 
of the pain testing procedures. In addition there were no group differences for changes in 
systolic BP or HR after any pain test.
Somatic Pain Sensitivity
There were no group differences in baseline APR from the phasic heat stimuli on the left 
hand (IBS=47.5 and HC=47.6) or WPRs from the right hand during 12°C water emersion 
(IBS=57.4 and HC=55.5). Mean WPRs were less than 1 during 32°C water emersion. The 
location of phasic heat stimuli on the palm did not affect pain ratings or the DNIC effect. All 
pain ratings were based on the scale ranging from 0 to 100.
IBS Clinical Pain Severity
IBS patients reported a mean symptom severity score of 251.9 on the Irritable Bowel 
Severity Scale (IBSS).43 This represents a moderate severity of IBS symptoms. This 
included 5 patients who rated the symptoms as mild, 13 as moderate, and 9 as severe. There 
were no differences on the IBSS scores, or on any demographic variable by IBS subtypes 
(IBS-D, IBS-C, and IBS-A).
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When comparing APR during baseline and during the painful CS of 12°C water, there was a 
significant main effect of DNIC (Fig. 1), indicating a DNIC effect across all participants 
[F=30.4 (1, 46), P<0.001, repeated measures ANOVA]. There was also a significant 
interaction effect (Fig. 1) between Group DNIC (APR with and without the CS) indicating a 
significant deficit in the DNIC effect for IBS patients compared with controls [F=6.97 (1, 
46), P=0.011, repeated measures ANOVA]. A post hoc analysis was carried out to 
determine whether IBS participants who had additional chronic pain conditions may have 
explained the group difference seen in DNIC. After controlling for IBS participants who 
reported having a second chronic pain condition, group differences in APR reductions 
(DNIC effect) remained significant [F=4.85 (1, 41), P=0.033, repeated measures ANOVA].
There was also a significant main effect (reduction in APR for the TS for both groups) using 
the nonpainful (32°C water) CS [F=12.5 (1, 46), P=0.001, repeated measures, ANOVA] 
(Fig. 1). However, there was not a significant difference between groups in the DNIC effect 
for APR [F=0.29 (1, 46), P=0.6, repeated measures, ANOVA]. Reductions in pain ratings 
during the nonpainful CS are due to nonspecific effects and cannot be related to endogenous 
analgesic mechanisms responsible for DNIC, which requires counterirritation from a 
noxious CS.
A repeated measures analysis of covariance comparing APR during the noxious 12°C CS 
counterirritation session to APR during the non-noxious 32°C CS counterirritation session 
shows greater group differences in DNIC in favor of HC, demonstrated by the enhanced 
interaction effect between Group X and DNIC [F=12.5 (1, 42) P=0.001, analysis of 
covariance]. Psychologic measures that were significantly different between IBS and HC 
groups (state anxiety, depression, anger-out expression of anger, and catastrophizing) were 
included as covariates in this analysis to control for these influences on pain ratings and 
DNIC.
A substantial effect size was seen for this interaction effect of group membership and DNIC 
(η2=0.23), whereas the effect size for all 4 psychologic measures combined was less than 
8% (depression η2=0.045, catastrophizing η2=0.015, anger-out expression η2=0.015, and 
state anxiety η2=0.001). This demonstrates an even greater deficit in the DNIC effect for 
IBS participants compared with HC participants and provides a measure of the true DNIC 
effect due to endogenous analgesic mechanisms after controlling for nonspecific effects, 
which are known to effect DNIC and pain measures.
Finally, in a post hoc analysis for IBS patients, the DNIC effect for APR was surprisingly 
not associated with symptom severity, as reported on the IBSS (r=0.2, P=0.31). However, 
symptom severity scores on the IBSS were associated with one of the psychologic measures, 
namely the catastrophizing subscale of the CSQ for IBS patients (r=0.46, P=0.016). There 
were no differences in the DNIC effect on APR within IBS subtypes (IBS-D, IBS-C, and 
IBS-A).
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The results of the present investigation demonstrate deficits in endogenous analgesic 
mechanisms for participants with IBS. The pain inhibitory mechanism responsible for DNIC 
was significantly impaired during concurrent noxious counterirritation (opposite hand 
immersion in painful 12°C water) in IBS participants compared with controls. There were 
also decreases in pain ratings during concurrent nonpainful 32°C CS. However, this latter 
condition reflects non-specific effects that are not due to counterirritation. These pseudo-
DNIC effects have rarely been accounted for in previous investigations of DNIC.18 
Although some investigators have used similar counter-balanced conditioned stimuli 
procedures to compare DNIC effects in noxious and non-noxious CS,18,45 results in these 
investigations simply stated that the group differences seen in DNIC during the true 
counterirritation protocol were not found in the non-noxious CS protocol. Only one other 
investigation has attempted to account for the role of nonspecific effects in DNIC outcome 
measures.18
It has been suggested that distraction from the CS may have contributed to the DNIC effects 
seen in earlier studies.11,13,18 Although distraction does not completely explain 
DNIC,27,46,47 it has a major influence on the modulation of pain perception.48 Tracey and 
Dunckley (2004)49 suggested that brain regions that are involved in hypervigilance may 
connect to brainstem structures responsible for DNIC leading to dysregulation of DNIC. 
Further, Reinert et al27 speculated that hypervigilance to the TS during DNIC procedures 
may disrupt DNIC, especially if the TS is meaningful, such as rectal distension for IBS 
patients,27 as seen in the Wilder-Smith et al IBS investigation of DNIC.26
We have extended the findings of the Wilder-Smith et al study and improved on the design 
for assessing DNIC in IBS participants in several important ways. (1) Non-specific effects 
were controlled for by counterbalancing 2 CS procedures. One used a noxious CS 
(submersion of the hand in 12°C water), whereas the other provided the identical stimuli 
(circulating water) in a non-noxious form (32°C). In addition, group differences in 
psychologic factors as reported on questionnaires were statistically controlled for in 
secondary analyses. (2) The DNIC effect was assessed using somatic pain for both the test 
and conditioning stimuli to avoid interference from peripheral sensitization (example, due to 
inflammation) that may be present in the gut of IBS participants. By using somatic pain test 
and conditioning stimuli, the DNIC measures more specifically reflect dysregulation in 
central pain mechanisms. (3) The DNIC effect of IBS participants with additional chronic 
pain syndromes were excluded without affecting the outcome of the study. The present 
investigation of endogenous analgesic mechanisms in IBS is the first study to extensively 
control for alternative explanations known to contribute to DNIC effects.
Limitations of This Study
We expected that individuals with deficient DNIC would have higher baseline APR from the 
phasic heat stimulus and higher pain ratings from the noxious water condition, but this was 
not the case in this investigation. Edwards et al18 and others21 also failed to demonstrate any 
associations between DNIC scores and other pain testing measures, such as pain threshold 
and tolerance from noxious heat stimuli. Edwards et al suggested that endogenous pain 
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modulating systems, such as DNIC, may be subserved by different mechanisms than those 
that govern less complex pain responses.18,50 Similarly, if deficits in DNIC play a role in 
IBS pain, it would be expected to correlate with pain severity (less DNIC would be 
associated with increased symptom severity). This was not the case with self-reported pain 
severity on the IBSS. One possible explanation is that the severity scores on the IBSS, at 
least in part, reflect psychologic factors like catastrophizing rather than, or in addition to 
pain symptoms. It may also be that psychologic factors play a larger role in simple pain 
measures, such as threshold, tolerance, than in the more complex DNIC process of pain 
modulation, but this requires further investigation.
Removing nonspecific effects from the DNIC effect is an important finding in this 
investigation; this was accomplished statistically by comparing 2 counterirritation protocols. 
Although this strategy differs from the traditional strategy, which compares pain ratings 
during a counterirritation protocol to pain ratings during a baseline protocol, it represents an 
important advancement in the study of DNIC in chronic pain disorders because it allows for 
the isolation of the endogenous analgesic mechanism effect on DNIC from nonspecific 
effects. Eliminating the confounds that can result from self-reported pain ratings can ideally 
be accomplished by direct observation of the physiologic mechanisms responsible for 
DNIC, such as alterations in functional magnetic resonance imaging activity of the caudal 
medulla,26 or alterations in the RIII reflex51 during pain testing. This would eliminate the 
subjectivity that results from pain reports and further improve upon our understanding of 
physiologic mechanisms that contribute to functional pain disorders.
In conclusion, the present study showed that IBS patients demonstrate compromised 
inhibitory regulation of phasic somatic pain stimuli. This disinhibition was independent of 
peripheral sensitization from the gut, cardiovascular reactivity, or psychologic mechanisms. 
Further investigation into central pain dysregulation in IBS may lead to improvements in 
diagnosis, and ultimately, to novel therapies for these patients.
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Average pain ratings of the phasic TS: Reductions in APR (the DNIC effect) from the 
baseline procedure (dark gray bar) to the APR during the concurrent tonic CS at 12°C 
(medium gray bar) demonstrate compromised DNIC in IBS participants compared with 
controls (F = 6.97, P = 0.011, repeated measures ANOVA). When nonspecific effects on 
group differences were controlled by comparing reductions in APR (DNIC effect) during the 
2 counterirritation protocols (12°C and 32°C, represented by the medium and light gray 
bars, respectively), and by including psychologic measures that differed by group as 
covariates, compromised DNIC was demonstrated in IBS participants compared with 
controls (F = 11.1, P = 002, ANCOVA). ANCOVA indicates analysis of covariance; 
ANOVA, analysis of variance; APR, average pain rating; C, Celsius; CS, conditioning 
stimuli; DNIC, diffuse noxious inhibitory control; IBS, irritable bowel syndrome; TS, test 
stimuli.
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TABLE 1
Group Mean (SEM) Scores for All Psychologic Questionnaires
Questionnaires Controls IBS
State anxiety 25.6 (1.6) 32.2 (1.7)*
Trait anxiety 29.4 (1.6) 33.6 (2.0)
Depression 1.9 (1.1) 4.8 (0.9)†
Anger expression 42.9 (0.75) 45.0 (0.7)
Anger-in expression 26.4 (0.56) 25.3 (0.57)
Anger-out expression 11.9 (0.64) 13.6 (1.0)†
Perceived stress 16.9 (1.5) 21.5 (1.8)





IBS indicates irritable bowel syndrome.
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